Asia-pacific Male Infertility Market Forecast 2023-2032

The Asia-Pacific male infertility market is set to grow with a 5.06% CAGR during the estimated period, 2023-2032. Key market growth drivers include increasing disposable income, rising awareness of male infertility, technological advancements, collaborations, and the establishment of fertility clinics.

MARKET INSIGHTS

The Asia-Pacific male infertility market growth assessment includes the analysis of South Korea, Japan, Australia & New Zealand, China, Thailand, Indonesia, India, Vietnam, and Rest of Asia-Pacific. The male infertility market in Indonesia is poised for growth due to notable industry advancements and the expansion of fertility centers and clinics across the country. These factors are expected to drive market growth in Indonesia in the forecast period.

Additionally, the male infertility market in Thailand is poised for growth due to the expansion of the medical tourism industry. Thailand is renowned for providing high-quality healthcare at affordable prices, making it a competitive destination for medical tourists. Also, the country's robust healthcare infrastructure, qualified medical staff, and accreditation by the Joint Commission International contribute to its appeal. The favorable combination of quality healthcare, affordable costs, and a thriving medical tourism sector positions Thailand as a key player in the male infertility market.

Furthermore, Vietnam offers state-of-the-art technology, impressive success rates, and affordable options for domestic and international patients. The country is also actively exploring integrating artificial intelligence into embryo diagnosis and monitoring, showcasing its commitment to harnessing advanced technologies for enhanced infertility solutions. As Vietnam's computer science field advances, the potential for AI to revolutionize infertility treatment and deliver tangible benefits to patients is promising.

COMPETITIVE INSIGHTS

Leading market players in the region include: Bayer Group, Zydus Lifesciences Ltd (Cadila Healthcare Ltd), etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 51589

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
- 2.5.1. PRODUCT DEVELOPMENTS AND LAUNCHES BY MARKET PLAYERS PROMOTE MARKET GROWTH
- 2.5.2. PREVALENCE OF DIABETES AND CANCER

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. SURGING INFERTILITY INCIDENCES
- 3.1.2. ASSISTED REPRODUCTIVE TECHNOLOGY ADOPTION
- 3.1.3. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
- 3.2.1. HIGH TREATMENT COSTS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS

5. MARKET BY TEST TYPE

5.1. DNA FRAGMENTATION TECHNIQUE
5.2. OXIDATIVE STRESS ANALYSIS
5.3. MICROSCOPIC EXAMINATION
5.4. SPERM AGGLUTINATION
5.5. COMPUTER-ASSISTED SEMEN ANALYSIS
5.6. SPERM PENETRATION ASSAY
5.7. OTHER TEST TYPES

6. MARKET BY TREATMENT

6.1. ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY
6.2. MEDICATIONS

7. GEOGRAPHICAL ANALYSIS

7.1. ASIA-PACIFIC
- 7.1.1. MARKET SIZE & ESTIMATES
- 7.1.2. ASIA-PACIFIC MALE INFERTILITY MARKET DRIVERS
- 7.1.3. ASIA-PACIFIC MALE INFERTILITY MARKET CHALLENGES
- 7.1.4. KEY PLAYERS IN ASIA-PACIFIC MALE INFERTILITY MARKET
- 7.1.5. COUNTRY ANALYSIS
  - 7.1.5.1. CHINA
  - 7.1.5.1.1. CHINA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.2. JAPAN
  - 7.1.5.2.1. JAPAN MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.3. INDIA
  - 7.1.5.3.1. INDIA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.4. SOUTH KOREA
  - 7.1.5.4.1. SOUTH KOREA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.5. INDONESIA
  - 7.1.5.5.1. INDONESIA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.6. THAILAND
  - 7.1.5.6.1. THAILAND MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.7. VIETNAM
  - 7.1.5.7.1. VIETNAM MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.8. AUSTRALIA & NEW ZEALAND
  - 7.1.5.8.1. AUSTRALIA & NEW ZEALAND MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.9. REST OF ASIA-PACIFIC
  - 7.1.5.9.1. REST OF ASIA-PACIFIC MALE INFERTILITY MARKET SIZE & OPPORTUNITIES

8. COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIC DEVELOPMENTS
- 8.1.1. MERGERS & ACQUISITIONS
- 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 8.1.3. PARTNERSHIPS & AGREEMENTS
- 8.1.4. BUSINESS EXPANSIONS
8.2. COMPANY PROFILES
- 8.2.1. ADVACARE PHARMA USA
  - 8.2.1.1. COMPANY OVERVIEW
  - 8.2.1.2. PRODUCTS / SERVICES LIST
- 8.2.2. ANDROLOGY SOLUTIONS
  - 8.2.2.1. COMPANY OVERVIEW
  - 8.2.2.2. PRODUCTS / SERVICES LIST
- 8.2.3. AYTU BIOPHARMA
  - 8.2.3.1. COMPANY OVERVIEW
  - 8.2.3.2. PRODUCTS / SERVICES LIST
  - 8.2.3.3. STRENGTHS & CHALLENGES
- 8.2.4. BAYER GROUP
  - 8.2.4.1. COMPANY OVERVIEW
  - 8.2.4.2. PRODUCTS / SERVICES LIST
  - 8.2.4.3. STRENGTHS & CHALLENGES
- 8.2.5. CAERUS BIOTECH
  - 8.2.5.1. COMPANY OVERVIEW
  - 8.2.5.2. PRODUCTS / SERVICES LIST
- 8.2.6. CINNAGEN CO
  - 8.2.6.1. COMPANY OVERVIEW
  - 8.2.6.2. PRODUCTS / SERVICES LIST
  - 8.2.6.3. STRENGTHS & CHALLENGES
- 8.2.7. EMD SERONO INC (MERCK SERONO)
  - 8.2.7.1. COMPANY OVERVIEW
  - 8.2.7.2. PRODUCTS / SERVICES LIST
  - 8.2.7.3. STRENGTHS & CHALLENGES
- 8.2.8. ENDO INTERNATIONAL PLC
  - 8.2.8.1. COMPANY OVERVIEW
  - 8.2.8.2. PRODUCTS / SERVICES LIST
  - 8.2.8.3. STRENGTHS & CHALLENGES
- 8.2.9. HALOTECH DNA
  - 8.2.9.1. COMPANY OVERVIEW
  - 8.2.9.2. PRODUCTS / SERVICES LIST
- 8.2.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
  - 8.2.10.1. COMPANY OVERVIEW
  - 8.2.10.2. PRODUCTS / SERVICES LIST
  - 8.2.10.3. STRENGTHS & CHALLENGES
- 8.2.11. SANOFI
  - 8.2.11.1. COMPANY OVERVIEW
  - 8.2.11.2. PRODUCTS / SERVICES LIST
  - 8.2.11.3. STRENGTHS & CHALLENGES
- 8.2.12. SCSA DIAGNOSTICS
  - 8.2.12.1. COMPANY OVERVIEW
  - 8.2.12.2. PRODUCTS / SERVICES LIST
- 8.2.13. THERAMEX
  - 8.2.13.1. COMPANY OVERVIEW
  - 8.2.13.2. PRODUCTS / SERVICES LIST
- 8.2.14. VITROLIFE
  - 8.2.14.1. COMPANY OVERVIEW
  - 8.2.14.2. PRODUCTS / SERVICES LIST
  - 8.2.14.3. STRENGTHS & CHALLENGES
- 8.2.15. ZYDUS LIFESCIENCES LTD (CADILA HEALTHCARE LTD)
  - 8.2.15.1. COMPANY OVERVIEW
  - 8.2.15.2. PRODUCTS / SERVICES LIST
  - 8.2.15.3. STRENGTHS & CHALLENGES

Product Code: 51589

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - MALE INFERTILITY
TABLE 2: ASIA-PACIFIC MALE INFERTILITY MARKET, BY TEST TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC MALE INFERTILITY MARKET, BY TEST TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC MALE INFERTILITY MARKET, BY TREATMENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: KEY PLAYERS OPERATING IN ASIA-PACIFIC MALE INFERTILITY MARKET
TABLE 9: LIST OF MERGERS & ACQUISITIONS
TABLE 10: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 11: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 12: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES

FIGURE 1: PORTER'S FIVE FORCES ANALYSIS
FIGURE 2: GROWTH PROSPECT MAPPING
FIGURE 3: MARKET MATURITY ANALYSIS
FIGURE 4: MARKET CONCENTRATION ANALYSIS
FIGURE 5: ASIA-PACIFIC MALE INFERTILITY MARKET, GROWTH POTENTIAL, BY TEST TYPE, IN 2022
FIGURE 6: ASIA-PACIFIC MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2032 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2032 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC MALE INFERTILITY MARKET, BY OXIDATIVE STRESS ANALYSIS, 2023-2032 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC MALE INFERTILITY MARKET, BY MICROSCOPIC EXAMINATION, 2023-2032 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC MALE INFERTILITY MARKET, BY SPERM AGGLUTINATION, 2023-2032 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC MALE INFERTILITY MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2023-2032 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC MALE INFERTILITY MARKET, BY SPERM PENETRATION ASSAY, 2023-2032 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC MALE INFERTILITY MARKET, BY OTHER TEST TYPES, 2023-2032 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2022
FIGURE 15: ASIA-PACIFIC MALE INFERTILITY MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY, 2023-2032 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC MALE INFERTILITY MARKET, BY MEDICATIONS, 2023-2032 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC MALE INFERTILITY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)
FIGURE 18: CHINA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 19: JAPAN MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 20: INDIA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 21: SOUTH KOREA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: INDONESIA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: THAILAND MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 24: VIETNAM MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: AUSTRALIA & NEW ZEALAND MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 26: REST OF ASIA-PACIFIC MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)